trial · primary record
ALTB-268
Ulcerative Colitis (UC)
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 24 |
| Primary completion | 2026-04-06 |
| Primary endpoint | To evaluate the safety and tolerability of ALTB-268 following intravenous (IV) infusion in healthy participants - Adverse Events |
| Registry ID | NCT07350577 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:47.387Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07350577
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.